Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
about
Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlatesImaging small vessel-associated white matter changes in aging.Incidence of symptomatic hemorrhage in patients with lobar microbleeds.Statin use following intracerebral hemorrhage: a decision analysis.Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?Correlation of Cerebral Microbleed Distribution to Amyloid Burden in Patients with Primary Intracerebral Hemorrhage.The pathophysiology and clinical presentation of cerebral amyloid angiopathy.Cerebral amyloid angiopathy in a young man with a history of traumatic brain injury: a case report and review of the literature.Emerging concepts in sporadic cerebral amyloid angiopathy.Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Cerebral amyloid angiopathy revealed by rapidly progressing leptomeningeal lesions.Core CSF biomarker profile in cerebral amyloid angiopathy: A meta-analysis.Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk.Use of polarized light microscopy is essential in the efficient diagnosis of respiratory amyloidosis and could decrease disease prevalence.
P2860
Q30450267-C42F5081-BBC5-422D-8434-D265C1D8271AQ30710587-1DD4FA71-2108-4709-A15B-B5E408AEA8E1Q35142625-C04B0AD6-BBFE-4598-814E-34515D7980CEQ35170660-0CECB0AF-5907-41D5-8AD2-5E09A6B26C90Q37662448-309B7107-C8B4-4240-A5E7-F8AF4D62CA63Q37708191-4AA21261-CF1A-4910-992C-397E9FCD6697Q38008170-48BD791B-0B15-4F07-A47C-F8DFFA6744A1Q38998315-35A9A821-FE22-439D-8D14-9931307DFA00Q39196370-1F2C98AE-F827-4FF8-8ACE-E0EB05DF0C36Q45425671-CC5FF9C5-AC26-4711-95A4-03FAC5D517E4Q47587631-FE652A92-5362-47C3-BB43-B3A0B2B87A89Q48769859-D642B569-8BC0-40B9-8979-F73D743E9E6BQ49545848-5302BC31-4DD7-4264-86A7-D7D130D96E3AQ49790347-E6FF265D-6043-4FB7-8F01-ABB2CA0FB332Q51583259-52E92DD5-6C9C-4072-B648-C53F90748238
P2860
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@ast
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@en
type
label
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@ast
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@en
prefLabel
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@ast
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@en
P2860
P1476
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
@en
P2093
Eric E Smith
Steven M Greenberg
P2860
P2888
P304
P356
10.1007/S11883-003-0048-4
P577
2003-07-01T00:00:00Z
P6179
1050365618